If, as expected, GW Pharmaceuticals obtains FDA approval for Epidiolex, an almost pure CBD anticonvulsant drug, it will be available by prescription and at a high price in the near future. Millions of families without insurance in the United States will not be able to buy it.
The pharmaceutical development of cannabinoid compounds is based on controlled experimentation with molecular strains, maintaining the assumption that sick people benefit more from predictable and reproducible medications that never vary. While strains can facilitate dose accuracy and confidence in the chemical composition of a drug, the monomolecular drug has serious drawbacks. Visit More https://foodsocietyx.com/cbd-gummies
No comments:
Post a Comment